Insights From AMCP Nexus 2022

Conference Coverage

Reviewing Newer Models, Current Role of Value-Based Contracts

10/17/2022

Samantha Matthews

A panel of experts at AMCP Nexus 2022 provided insight on selecting and implementing value-based arrangements and the challenges that may arise.

A panel of experts at AMCP Nexus...

10/17/2022

First Report Managed Care

Conference Coverage

Payer Challenges for Managing Drugs Granted Accelerated Approval by the FDA

10/14/2022

Maria Asimopoulos

Speakers at AMCP Nexus 2022 reviewed how the accelerated approval pathway complicates payer decision-making, as well as some proposed reforms to alleviate issues related to data and costs.

Speakers at AMCP Nexus 2022...

10/14/2022

First Report Managed Care

Conference Coverage

Upcoming Federal Legislative, Regulatory Updates

10/14/2022

Samantha Matthews

The AMCP Policy and Government Relations team discusses the latest and upcoming federal legislative and regulatory updates regarding health policy at AMCP Nexus 2022.

The AMCP Policy and Government...

10/14/2022

First Report Managed Care

Conference Coverage

Significant Economic Burden, Direct Medical Costs Among OAs With RSV Infections

10/12/2022

Samantha Matthews

Researchers estimated the annual economic burden of respiratory syncytial virus among adults aged 60 years and older in the United States.

Researchers estimated the annual...

10/12/2022

First Report Managed Care

Conference Coverage

Using Real-World Evidence to Analyze Economic, Clinical Benefit of Medication for Addiction Treatment

10/12/2022

Samantha Matthews

Recent data shows members with opioid use disorder or overdose who use medication for addiction treatment may incur lower costs.

Recent data shows members with...

10/12/2022

First Report Managed Care

Conference Coverage

HCRU, Costs by Treatment Modality for Patients With Newly Diagnosed Major Depressive Disorder

10/07/2022

Jolynn Tumolo

“In this real-world sample of commercially insured patients, we observed variations in outcomes by treatment modality and an association between modality and disease severity,” said researchers at AMCP Nexus 2022.

“In this real-world sample of...

10/07/2022

First Report Managed Care

Conference Coverage

Digital Therapeutics: Assessing Payer Perception, Formulary Decision Trends

10/07/2022

Samantha Matthews

“Coverage appears to be more likely for prescription-only digital therapeutics; however, challenges with proof of long-term benefit, patient adherence, and fulfillment remain,” said authors of a poster presented at AMCP Nexus 2022.

“Coverage appears to be more...

10/07/2022

First Report Managed Care

Insights From AMCP Nexus 2022

Specialties

Events

Year Round Education

HMP Global Products